Trial intelligence / Profile preview

Modified Dahuang Huanglian Xiexin Mouthwash for the Prevention of Radiotherapy-Induced Oral Mucositis

NCT07543978Phase 3Not yet recruiting

Start
Apr 2026
Primary completion
Apr 2027
Modality
Small Molecules
01

Overview

A Phase 3 trial of modified dahuang huanglian xiexin mouthwash in oral mucositis (OM). Planned start Apr 2026; status: not yet recruiting.

02

Drugs

modified dahuang huanglian xiexin mouthwash
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT07543978.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07543978.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call